Get started
Author

Rahuman Salim

Liposomal Amphotericin B (AmBisome®): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions
2016 · Neil R. H. Stone, Tihana Bicanic, et al. · Drugs · 531
Molecular MRD status and outcome after transplantation in NPM1-mutated AML
2020 · Richard Dillon, Robert Hills, et al. · Blood · 168
PDF
Augmented Reduced-Intensity Regimen Does Not Improve Postallogeneic Transplant Outcomes in Acute Myeloid Leukemia
2020 · Charles Craddock, Aimee Jackson, et al. · Journal of Clinical Oncology · 161
PDF
Posttransplant MRD and T-cell chimerism status predict outcomes in patients who received allografts for AML/MDS
2023 · Justin Loke, Nicholas McCarthy, et al. · Blood Advances · 49
Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman–Diamond syndrome: a retrospective analysis and a review of the literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP-EBMT)
2020 · Simone Cesaro, Marta Pillon, et al. · Bone Marrow Transplantation · 47
Plerixafor is superior to conventional chemotherapy for first-line stem cell mobilisation, and is effective even in heavily pretreated patients
2014 · R E Clark, J Bell, et al. · Blood Cancer Journal · 32
PDF
Chronic Lymphocytic Leukaemia Developing in the Course of Chronic Myeloid Leukaemia
2002 · R. Salim, L. Wang, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 16
Myelodysplastic syndrome with trisomy 8 associated with Behçet syndrome: An immunologic link to a karyotypic abnormality
2006 · Jecko V. Thachil, Rahuman Salim, et al. · Pediatric Blood & Cancer · 14
A population study showing that the advent of second generation tyrosine kinase inhibitors has improved progression-free survival in chronic myeloid leukaemia
2013 · Sebastian Francis, Claire Lucas, et al. · Leukemia Research · 12
Thrombocytopenia with rituximab treatment—splenomegaly as the risk factor
2009 · Jagdish Adiyodi, Jecko Thachil, et al. · Annals of Hematology · 9
Campath-1H induced pure red cell aplasia in a patient with chronic lymphatic leukaemia
2006 · Jecko Thachil, Rahuman Salim · Leukemia Research · 6
Reducing the diversity of allogeneic transplant protocols in the UK through a BSBMT Anthony Nolan Protocol Harmonization Initiative
2020 · Chloe Anthias, Jane Apperley, et al. · Bone Marrow Transplantation · 5
PDF
The Sequential Flamsa-Bu Conditioning Regimen Does Not Improve Outcome in Patients Allografted for High Risk Acute Myeloid and Myelodysplasia Irrespective of Pre-Transplant MRD Status: Results of the UK NCRI Figaro Trial
2019 · Charles Craddock, Aimee E Jackson, et al. · Blood · 5
Correction: Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman–Diamond syndrome: a retrospective analysis and a review of the literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP-EBMT)
2020 · Simone Cesaro, Marta Pillon, et al. · Bone Marrow Transplantation · 1
PDF
Early Absolute Lymphocyte Count Is a Strong Predictor of Long Term Improved Survival in Childhood Acute Myeloid Leukaemia
2012 · Russell Keenan, Rebecca Williamson, et al. · Blood · 1
T cell function in chronic myeloid leukemia and its treatment with tyrosine kinase inhibitors—Clues from and for sarcoidosis
2009 · Maqsood Punekar, Jecko Thachil, et al. · Leukemia Research · 1
Post-Transplant MRD Status and T Cell Chimerism Predict Outcomes in Patients Allografted for AML/MDS-a Prospective Analysis from the UK NCRI Figaro Trial
2022 · Justin Ching Ting Loke, Nicholas McCarthy, et al. · Transplantation and Cellular Therapy
Post-Transplant MRD Status and T Cell Chimerism Predict Outcomes in Patients Allografted for AML/MDS-a Prospective Analysis from the UK NCRI Figaro Trial
2021 · (Justin) Ching Ting Loke, Nicholas McCarthy, et al. · Blood
Results of allogeneic stem cell transplantation in patients affected by Shwachman-Diamond syndrome. A retrospective study of SAA-EBMT
2018 · Simone Cesaro, Gloria Tridello, et al. · Data Archiving and Networked Services (DANS)
De-escalation of Tyrosine Kinase Inhibitor Therapy Is Safe in Chronic Myeloid Leukaemia in Durable Molecular Response (>= Mr3 for >= 12 Months): Initial Results in the British Destiny Study
2016 · Richard E. Clark, Fotis Polydoros, et al.
The Use of Pegylated G-CSF in Chronic Neutropaenia of Childhood. A Single Centre Experience
2012 · Cathy Benfield, Victoria Brown, et al. · Blood
Works count: 21
Citation count: 1,058
H-index: 9
I10-index: 9
Year
Topic
Type